Feb. 8, 2012 at 10:20am
BAYERBAYER HEALTHCARE PHARMACEUTICALSBEYAZBlood ClotsCVSTDROSPIRENONEDRSPDRSP/EEDVTDeep Vein ThrombosisFDAGIANVIMass TortsOCELLAPEPharmaPulmonary EmboliSAFYRALStrokesYASMINYAZcardiac arrythmiaYAZ VICTIMSDRSP LAWSUITSDROSPIRENONE LAWSUITS

February 8, 2012 - Sixty (60) Days After FDA Advisory Committee Vote on DRSP (DROSPIRENONE) Containing Birth Control Pills.

Prior to #FDA Advisory Committee hearings, held on 12/8/11, regarding #DRSP (#DROSPIRENONE) containing birth control pills, the manufacturer released a newsletter confirming that it had been ‘served’ with 10,400 lawsuits alleging personal injuries or death. This figure was an estimate as of 10/8/11, two months before the FDA Advisory Committee hearings would consider the latest FDA funded study confirming the pills present a significantly higher risk to users of blood clots that is estimated at 75%-77% higher in comparison to other pills. This finding was released by FDA in late October 2011.

The FDA Advisory Committee voted 15-11 that the pills effectiveness in prevention of pregnancy outweighed their safety risks. This narrow vote of confidence meant the pills barely survived a recommendation that they be the subject of a ‘recall’ or ‘market withdrawal’. Recently released transcripts of the FDA Advisory Committee vote arguably reveal confusion on the vote and a missed opportunity to intervene on behalf of a Generation of #DRSP (#DROSPIRENONE) Vicitms, or YAZ VICTIMS. The FDA Advisory Committee also voted, and recommended, an updated warning label to reflect new and emerging scientific evidence that the pills in fact present higher risks of blood clots to users of all ages. Official FDA action the Advisory Committee recommendations remain pending today - February 8, 2012 - 60 (sixty) days after the Advisory Meeting met and held public hearings.

Gabriel F. Zambrano, P.A., is the author of this commentary. Gabriel F. Zambrano, P.A. is actively investigating cases of blood clots- for YAZ VICTIMS - from the use of #DRSP (#DROSPIRENONE) containing birth control pills: #YASMIN, #YAZ, #BEYAZ, #SAFYRAL, #OCELLA and #GIANVI, as well as related generic equivalents.  Additional information is available from Gabriel F. Zambrano, P.A., or by contacting this office directly.

(Source: yazrecall.com)

Jul. 28, 2011 at 7:33pm
TylenolTylenol LawsuitsAcetaminophen OverdoseAcetaminophen LawyersAcetaminophen LawsuitsLiver FailureOrgan FailureLiver Transplant@gfzambranoGabriel F ZambranoPharmaPharmaceuticalsLawFDANPRJohnson & Johnson
#Tylenol manufacturer, J&J, announces dosage reduction for #acetaminophen pills. As noted in prior posts, acetaminophen overdose is the leading cause of liver failure in the US. The image above leads to NPR story on J&J’s change to reduce liver failure. Gabriel F. Zambrano, P.A., is the sponsor of this post and commentary. Gabriel F. Zambrano, P.A., is investigating cases involving acetaminophen overdose involving death or serious injuries.

#Tylenol manufacturer, J&J, announces dosage reduction for #acetaminophen pills. As noted in prior posts, acetaminophen overdose is the leading cause of liver failure in the US. The image above leads to NPR story on J&J’s change to reduce liver failure.

Gabriel F. Zambrano, P.A., is the sponsor of this post and commentary. Gabriel F. Zambrano, P.A., is investigating cases involving acetaminophen overdose involving death or serious injuries.